Clinical Impact of Selective and Non-selective Beta Blockers on Survival in Ovarian Cancer Patients

BACKGROUND: Preclinical evidence suggests that sustained adrenergic activation can promote ovarian cancer growth and metastasis. We examined the impact of beta-adrenergic blockade on clinical outcome of women with epithelial ovarian, primary peritoneal or fallopian tube cancers (collectively, EOC)....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer
Autors principals: Watkins, Jack L., Thaker, Premal H., Nick, Alpa M., Ramondetta, Lois M., Kumar, Sanjeev, Urbauer, Diana L., Matsuo, Koji, Squires, Kathryn, Lutgendorf, Susan K., Ramirez, Pedro T., Sood, Anil K.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4575637/
https://ncbi.nlm.nih.gov/pubmed/26301456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29392
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars